thiotepa has been researched along with Experimental Lung Inflammation in 8 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Experimental Lung Inflammation: Inflammation of any part, segment or lobe, of the lung parenchyma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-dose chemotherapy given with autologous bone marrow support has resulted in significant tumor responses in the majority of patients with metastatic breast cancer, a minority of which are durable." | 6.67 | Dose escalation of mitoxantrone given with thiotepa and autologous bone marrow transplantation for metastatic breast cancer. ( Adkins, D; Bowers, C; Dunphy, F; Harrison, B; LeMaistre, CF; Spitzer, G, 1993) |
| "Our aim was to describe the incidence, clinical course, and risk factors for idiopathic pneumonia syndrome (IPS) after high-dose chemotherapy with cyclophosphamide, carmustine, and thiotepa followed by autologous stem cell transplantation for high-risk breast cancer." | 3.72 | Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer. ( Champlin, RE; Giralt, SA; Rondon, G; Saliba, RM; Shannon, VR; Ueno, NT; Wong, R, 2003) |
| "High-dose chemotherapy given with autologous bone marrow support has resulted in significant tumor responses in the majority of patients with metastatic breast cancer, a minority of which are durable." | 2.67 | Dose escalation of mitoxantrone given with thiotepa and autologous bone marrow transplantation for metastatic breast cancer. ( Adkins, D; Bowers, C; Dunphy, F; Harrison, B; LeMaistre, CF; Spitzer, G, 1993) |
| "No idiopathic pneumonitis syndrome cases were reported in our cohort." | 1.48 | Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma. ( Avni, B; Grisariu, S; Or, R; Shapira, MY, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grisariu, S | 1 |
| Shapira, MY | 1 |
| Or, R | 1 |
| Avni, B | 1 |
| Wong, R | 1 |
| Rondon, G | 1 |
| Saliba, RM | 1 |
| Shannon, VR | 1 |
| Giralt, SA | 1 |
| Champlin, RE | 1 |
| Ueno, NT | 1 |
| CHEEVER, AW | 1 |
| VALSAMIS, MP | 1 |
| RABSON, AS | 1 |
| Ridola, V | 1 |
| Grill, J | 1 |
| Doz, F | 1 |
| Gentet, JC | 1 |
| Frappaz, D | 1 |
| Raquin, MA | 1 |
| Habrand, JL | 1 |
| Sainte-Rose, C | 1 |
| Valteau-Couanet, D | 1 |
| Kalifa, C | 1 |
| Zolotovskiĭ, BB | 1 |
| Prostov, IK | 1 |
| Litvinenko, TG | 1 |
| Bowers, C | 1 |
| Adkins, D | 1 |
| Dunphy, F | 1 |
| Harrison, B | 1 |
| LeMaistre, CF | 1 |
| Spitzer, G | 1 |
| Nemchinov, NN | 1 |
| Shurina, NA | 1 |
1 trial available for thiotepa and Experimental Lung Inflammation
| Article | Year |
|---|---|
Dose escalation of mitoxantrone given with thiotepa and autologous bone marrow transplantation for metastatic breast cancer.
Topics: Adult; Bone Marrow; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Dose-R | 1993 |
7 other studies available for thiotepa and Experimental Lung Inflammation
| Article | Year |
|---|---|
Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabin | 2018 |
Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cyclophosphamid | 2003 |
NECROTIZING TOXOPLASMIC ENCEPHALITIS AND HERPETIC PNEUMONIA COMPLICATING TREATED HODGKIN'S DISEASE. REPORT OF A CASE.
Topics: Alkylating Agents; Antineoplastic Agents; Cyclophosphamide; Encephalitis; Herpesviridae Infections; | 1965 |
High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Busulfan; Cerebellar Neoplasms; Child | 2007 |
[Role of conditionally pathogenic microbes in the development of experimental destructive pneumonia].
Topics: Animals; Dogs; Escherichia coli Infections; Female; Immunologic Deficiency Syndromes; Lung; Male; Pn | 1981 |
[Thiophosphamide in the overall treatment of chronic pneumonia].
Topics: Adult; Aged; Chronic Disease; Drug Hypersensitivity; Humans; Middle Aged; Pneumonia; Remission, Spon | 1976 |
[Comparative characteristics of serum proteins during benign and malignant diseases of the lungs].
Topics: Adult; Blood Protein Electrophoresis; Female; Humans; Lung Neoplasms; Male; Methods; Middle Aged; Pn | 1967 |